Genomics into health

As genomic experts, we have a comprehensive understanding of how innovative technologies can contribute to more effective healthcare

We work with policy-makers, clinicians, academia and industry to develop future-focused healthcare strategies for safe and suitable use of innovations, such as diagnostics, genome editing and regenerative medicines. Only through understanding the benefits - and complexities - of genomics-based innovations and other 'omics sciences can we help everyone benefit from great science.

Explainer Pandemic in the genomic era

Genomics is proving its worth in the battle against infectious disease, including COVID-19.

Report Polygenic scores and clinical utility

Our report unpicks the complexities of assessing the clinical utility of polygenic scores

Report Pathogen Genomics Into Practice

Converting genomics into population wide, high quality, evidence based pathogen services

Report The GDPR and genomic data

How does ‘personal data’ apply to genomics, and what does this mean for research and healthcare?

Policy briefing ctDNA technology in lung cancer: personalised healthcare in action

Blog Expanding the public and patient role in medical regulation

6 July 2021

A recent consultation by the UK Medicines and Healthcare products Regulatory Agency (MHRA) indicates a welcome new direction for public and patient involvement (PPI).

Blog Putting Genome UK into practice

18 May 2021

Blog Bringing order to polygenic score reporting

14 April 2021

Inconsistencies in the way polygenic score models are reported could delay their introduction into healthcare. Two very welcome (in our opinion) new papers aim to bring order to the field

Report The ethical and legal framework for a Genomics England and Sano Genetics participant engagement platform

12 April 2021

Commissioned by Genomics England, our new report examines the legal and ethical implications of an online platform for patient engagement in precision medicine research being developed by Sano Genetics

Research Infectious disease and genomics

19 March 2021

Knowledge emerging from the genomic sequencing of pathogens is fuelling more effective interventions to prevent and manage the spread of infectious diseases

Explainer What is clinical utility?

1 March 2021

Evidence of clinical utility is a key requirement of healthcare evaluation frameworks, however, demonstrating this is not straightforward

Blog Personalising therapy for age-related macular degeneration

10 February 2021

Gene therapy holds new hope for AMD patients. If successful they will be beneficial to patients for whom no current therapies are available or do not work.